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Abstract
Objective: To evaluate the capacity of computer analysis of antepartum cardiotocographs performed by SisPorto1 2.0 in predicting
neonatal outcome. Study design: A prospective observational study was conducted in eight tertiary care centres in Europe and Australia,
involving pregnant women in the absence of labor, scheduled for elective caesarean section, whose last fetal heart rate (FHR) tracing was
performed within 4 h of delivery. After exclusion of fetal malformations, multiple pregnancies, tracings with less than 30 min, tracings with
more than 15% signal loss, difficult fetal extractions, and anesthesia complications, a total of 345 cases were analyzed. Computer
quantification of cardiotocographic parameters was compared with newborn Apgar score, umbilical artery pH, metabolic acidosis and
neonatal hypoxic-ischemic encephalopathy, by means of receiver operating characteristic (ROC) curves. Results: Acceleration number, mean
short-term variability, percentage of abnormal short-term variability and percentage of abnormal long-term variability had an excellent
discriminative capacity to predict 1-min Apgar scores under or equal to 4 (areas under the ROC curve 0.96–1.00). The same parameters
showed a slightly lower capacity to predict 5-min Apgar scores under or equal to 6 (areas under the ROC curve 0.81–0.89). The best cut-off
values for these parameters, derived from the previously referred calculations, detected all cases of hypoxic-ischemic encephalopathy (n ¼ 2).
Cardiotocographic parameters showed a lower discriminative capacity in prediction of umbilical artery pH <7.20 (maximum area under the
ROC curve 0.66) and <7.15 (maximum area under the ROC curve 0.69). Conclusions: Computerized quantification of accelerations and
variability in the antepartum allows a good prediction of 1 and 5-min Apgar scores, and to a much lesser degree umbilical artery pH.
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1. Introduction
More than 30 years after the introduction of antepartum
cardiotocography into clinical practice, the predictive capa-
city of the method remains controversial. In a review of 45
articles published on this subject, Devoe et al. found that its
reported sensitivity varies between 2 and 100%, and its
specificity between 37 and 100% [1]. Similar results are
reported in other reviews [2,3]. There are many possible
explanations for these discrepant numbers. Different cardi-
otocographic equipment was used in the studies, as well as
different criteria for interpreting fetal heart rate (FHR)
tracings, and varying definitions of poor neonatal outcome.
Many studies were performed before important aspects of
FHR analysis started to be taken into account, such as FHR
variability and the existence of fetal behavioral states.
Another important issue is the time interval that elapsed
between the end of the study tracing and evaluation of
neonatal state at delivery. In some studies this interval
exceeded 1 week, in some it is not revealed, and in others
it comprises situations capable of inflicting a significant
stress to the fetus, such as labor. Intervention bias can also be
problem, in what is known as the ‘‘treatment paradox’’:
when FHR tracings associated with fetal stress, but not
distress, are considered a ‘‘positive test’’ and an intervention
is performed, a high number of false positives may occur,
because poor outcome was effectively avoided by interven-
tion. Finally, interpretation of these results must take into
account the well-demonstrated poor reproducibility of visual
analysis [4].
Randomized trials on antepartum cardiotocography have
failed to show a difference in the incidence of low Apgar
scores, elective caesareans, induced labours, neonatal neu-
rological outcome, intensive care unit admissions or peri-
natal mortality [5]. However, it must be emphasised that all
these trials were conducted in the early 1980’s when other
methodologies for fetal evaluation were common practice,
they evaluated a relatively small number of cases, and used
very different FHR monitoring intervals. A detailed analysis
of clinical records in the few cases of fetal death showed that
mortality in both groups could largely be explained by
intrapartum events [6].
Computer analysis of cardiotocographs has the theoretical
advantage of providing a reproducible and objective inter-
pretation of FHR tracings, quantifying parameters that are
difficult to assess by the human eye, such as short- and long-
term variability. Such systems have been developed since the
late 1970’s [7] but have still to gain wide clinical acceptance.
This may be related to the limited demonstration of their
validity and efficacy, as well as to the poor practicality of
their routine clinical use. SisPorto1 2.0 is a program for
automated analysis of tracings, developed over the last 14
years at the University of Porto. FHR baseline is calculated
using a complex algorithm developed to identify the mean
FHR during stable segments, in the absence of fetal move-
ments and uterine contractions [8]. Accelerations are defined
as increases in the FHR above the baseline, lasting 15–120 s
and reaching a peak of at least 15 bpm. Decelerations are
defined as decreases in the FHR under the baseline, lasting at
least 15 s and with an amplitude exceeding 15 bpm. They are
classified as mild if shorter than 120 s, prolonged if they last
120–300 s, and severe if they exceed 300 s. Points with
abnormal short-term-variability (STV) are recognised when
the difference to adjacent FHR signals is less than 1 bpm.
Points with abnormal long-term variability (LTV) are iden-
tified whenever the difference between maximum and mini-
mum FHR values of a sliding 60-s window centered on
them, does not exceed 5 bpm. The system is extensively
described elsewhere [8].
The main objective of this study was to evaluate the
capacity of SisPorto1 2.0’s FHR parameters to predict
various indicators of neonatal outcome (1 and 5-min Apgar
score, umbilical artery pH, metabolic acidosis and neonatal
hypoxic-ischemic encephalopathy). The least possible inter-
val between FHR monitoring and newborn evaluation was
aimed at, with further exclusions of cases where situations
associated with fetal stress occurred during this interval.
2. Materials and methods
A prospective multicentre observational study was con-
ducted in which all tracings were acquired with Doppler
ultrasound using Sonicaid1 Meridien 800, Hewlett-Pack-
ard1 M1350A, M1350B or M1351-3 fetal monitors, con-
nected by cable to a personal computer running the
SisPorto1 2.0 program. Necessary criteria for inclusion
were the acquisition of tracings with at least 30 min duration
and less than 15% signal loss. Exclusion criteria were
multiple gestations, and fetal malformations diagnosed
before or after birth. In order to minimize the biases that
were referred to previously, only women scheduled for
elective cesarean section in the absence of labor, whose
FHR tracings were acquired within the 4 h that preceded
delivery, were included. The study population thus consisted
mainly of in-patients from high-risk obstetric wards of
tertiary care hospitals, with an established indication for
elective cesarean section, based on criteria that did not take
into account the results of computer FHR analysis. Women
operated under general and regional anesthesia were
included, as there is no evidence that this significantly
influences neonatal outcome [9,10]. On the other hand,
difficult fetal extractions during cesarean section (n ¼ 2)
and anesthesia complications occurring before or during
surgery (n ¼ 1) were excluded, as these have been asso-
ciated with neonatal acidemia [10,11]. This information was
obtained from the Obstetricians and Anesthesiologists
involved in the procedures.
In each case, the last available FHR tracing lasting 30–
60 min was evaluated, and the following parameters were
extracted from the SisPorto1 2.0 analysis: FHR baseline,
number of accelerations, percentage of the tracing with
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abnormal short-term variability, average short-term varia-
bility, percentage of the tracing with abnormal long-term
variability, average long-term variability, and number of
mild, prolonged, and severe decelerations.
Apgar scores at 1, 5, and 10 min were evaluated by the
health caregivers responsible for immediate neonatal sup-
port in each participating center. The cut-off values con-
sidered clinically most meaningful were selected: 1-min
Apgar score 4, 5-min Apgar score 6, and 10-min Apgar
score 6. For evaluation of umbilical blood gas values, the
cord was doubly clamped immediately after birth and within
30 min blood was aspirated from both artery and vein into
two previously heparinized syringes. After vestigial air was
expelled and the needle protected, blood gas analysis was
carried out within 30 min using the equipment available in
each center [12,13]. Cases with no data on either arterial and
venous samples, and those in which pH values differed by
less than 0.03 units, or PCO2 values differed by less than
7.5 mm Hg, were excluded from the analysis of this para-
meter [14]. Cut-off values for arterial pH at 7.15 and 7.20
were evaluated. Metabolic acidosis was defined as an umbi-
lical artery pH <7.05 and an extracellular fluid base deficit
exceeding 12 mmol/l. In newborns with arterial pH <7.10, 1-
min Apgar score 4, or 5-min Apgar score 6, (n ¼ 11)
hospital records were reviewed for the diagnosis of hypoxic-
ischemic encephalopathy. This was defined as the appear-
ance of changes in muscle tone, feeding, state of conscience
or seizures occurring in the first 48 h of life.
A total of 345 cases were included in the study. The
number of cases included and excluded in each participating
center is displayed in Table 1. Ethical committee approval
for the study and informed consent for enrollment of sub-
jects was obtained in all participating centers.
2.1. Statistical methods
The capacity of each FHR parameter to predict neonatal
outcome indicators was evaluated by means of receiver
operating characteristic (ROC) curves [15]. Areas under
the ROC curve were calculated with 95% confidence inter-
vals (CI). The best cut-off value was chosen as the one with
the highest sensitivity and specificity. For calculation
of statistical data SPSS for Windows1 version 10.0.7 was
used.
3. Results
Maternal age varied between 16 and 43 years, with an
average of 30 and a standard deviation of 5. Risk factors for
fetal hypoxia in the study population are displayed in
Table 2. The majority of cases (60.9%) had no identifiable
risk factors. Median gestational age was 38 weeks, with a
minimum of 25 and maximum of 42. One woman had a
gestational age of less than 28 weeks, in five it was between
28 and 30 weeks, in 10 between 30 and 32 weeks and in 16
cases between 32 and 34 weeks.
Newborns weighed between 750 and 4570 g, with an
average of 3023 g and a standard deviation of 801. Fifty-
one percent were female and 49% male. Endotracheal intuba-
tion in the delivery ward was carried out in 22 cases (6%) and
there were 53 neonatal intensive care unit admissions (15%).
Two neonatal deaths occurred: one on the 4th day after birth
caused by a hyperglycemic coma and the other on the 7th day
due to sepsis of a probable intrauterine origin.
Eight newborns were attributed a 1-min Apgar score 4,
six a 5-min Apgar score 6 and two a 10 min Apgar score
6. Of the 270 cases with valid umbilical blood gas values,
46 had an arterial pH <7.20, 15 a pH <7.15, two a pH <7.10
and one a pH <7.05. There were no cases of metabolic
acidosis. In two newborns the diagnosis of hypoxic-ischemic
encephalopathy was established; one of them grade II and
the other grade III with subsequent neonatal death on the 7th
day of life. The Apgar scores of these two cases were 3/6/7
and 4/8/8, respectively. In the first case umbilical blood
samples were not collected, and in the second an arterial pH
of 7.15 and a base deficit of 11 mmol/l were recorded.
The small number of cases with 10-min Apgar score 6
(n ¼ 2), hypoxic-isquemic encephalopathy (n ¼ 2) and
metabolic acidosis (n ¼ 0) precluded a formal evaluation
of the validity of FHR parameters in the prediction of these
outcomes. The number of valid neonatal parameters, their
median, 2.5 and 97.5 percentiles, minimum and maximum
values are considered in Table 3.
Table 1
Number and source of included and excluded cases
Participating centers Included Excluded
Aachen University Hospital, Germany 39 2
Calvary Hospital, Adelaide, Australia 18 3
Glan Clwyd Hospital, Rhyl, United Kingdom 23 6
Hospitais da Universidade de Coimbra, Portugal 26 8
Hospital Santo Anto´nio, Porto, Portugal 50 8
Hospital Sa˜o Joa˜o, Porto, Portugal 151 35
Hospital Vall d’Hebron, Barcelona, Spain – 24
University Women’s Hospital, Basel, Switzerland 38 2
Total 345 88
Table 2
Risk factors for fetal hypoxia in the study population
Number
Maternal diabetes 22
Other severe maternal health conditions 14
Pre-eclampsia without detected fetal compromise 28
Fetal growth restriction, oligohydramnius and/or
altered diastolic umbilical blood flow
53
Rh immunization 3
Isolated cardiotocographic abnormalities 5
Placenta previa 10
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Accelerations occurred in 319 tracings (92%) and pro-
longed decelerations (2–5 min) in 3 (1%). No tracings
demonstrated severe (>5 min) or repetitive decelerations
[6]. Other characteristics of the distribution of FHR para-
meters are considered in Table 3. Analysis of the different
types of decelerations is not included in the ROC figures, as
it failed to provide satisfactory discriminative capacities.
3.1. Prediction of 1-min Apgar score 4
Both cases that went on to develop hypoxic-ischemic
encephalopathy were included in this group. The capacity of
FHR parameters to predict this outcome is displayed in
Fig. 1, by means of ROC curves and areas under these
curves. A scatter graph comparing the distribution of 1-min
Apgar score with the percentage of abnormal LTV is shown
in Fig. 2.
The FHR parameters with best discriminative capacities
(accelerations, percentage of abnormal short-term variabil-
ity and percentage of abnormal long-term variability) were
also analyzed in combination, using the best cut-off values
arrived at by individual analysis. Tracings without accel-
erations were evaluated to assess whether the quantification
of abnormal short and long-term variability would discri-
minate between cases with low and high 1-min Apgar
scores. In Fig. 2 a scatter graph relating abnormal long-term
variability with 1-min Apgar scores in the 26 cases without
accelerations is shown.
Absence of accelerations combined with abnormal long-
term variability >30.5% obtained a sensitivity of 100%
(95%CI: 63–100) and a specificity of 99% (95%CI: 97–
100) in predicting 1-min Apgar score 4. Three false
positives and no false negative occurred in this evaluation.
The area under the ROC curve for this evaluation was 0.997
(95%CI: 0.992–1.000. When absence of accelerations was
combined with abnormal short-term variability >63.5%,
sensitivity was 100% (95%CI: 63–100) and specificity
98% (95%CI: 95–99). Abnormal long-term variability
>30.5% combined with abnormal short-term variability
>63.5% obtained a sensitivity of 100% (95%CI: 63–100)
and a specificity of 99% (95%CI: 97–100). The combination
of all three parameters provided a sensitivity of 100%
(95%CI: 63–100) and a specificity of 97% (95%CI: 95–
99). If FHR baseline above 150 bpm was combined with the
Table 3
Main characteristics of neonatal and FHR parameters in the study population
n Median Percentile 2.5 Percentile 97.5 Minimum Maximum
1-min Apgar score 342 9 5 10 1 10
5-min Apgar score 342 10 7 10 4 10
10-min Apgar score 190 10 9 10 5 10
Arterial pH 270 7.27 7.11 7.35 7.05 7.37
FHR baseline 345 130 110 149 110 171
Acceleration number 345 13 0 37 0 47
Percentage of abnormal STV 345 53 29 75 25 88
Mean STV 345 1.1 0.5 4.1 0.3 11.9
Percentage of abnormal LTV 345 2 0 37 0 95
Mean LTV 345 8.7 1.7 19.6 0.4 23.5
Prolonged decelerations 345 0 0 0 0 2
STV: short-term variability, LTV: long-term variability.
Fig. 1. ROC curves for the prediction of 1-min Apgar 4 (n ¼ 8) by the studied FHR parameters. On the right, areas under the ROC curves, 95% confidence
intervals, and best cut-off values for each parameter. STV: short-term variability, LTV: long-term variability.
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absence of accelerations and abnormal long-term variability
>30.5%, sensitivity decreased to 12% (95%CI: 1–53), but
specificity remained at 99% (95%CI: 98–100). None of the
cases with low 1-min Apgar score exhibited prolonged,
severe or repetitive decelerations.
3.2. Prediction of 5-min Apgar score 6
Five of the six cases with 5-min Apgar score6 also had a
1-min Apgar score4. The ROC curves for the prediction of
this outcome by FHR parameters are displayed in Fig. 3.
Combinations of FHR parameters were also evaluated,
using the best cut-off values obtained with individual ana-
lysis. Absence of accelerations combined with abnormal
long-term variability >30.5% provided a sensitivity of 83%
(95%CI: 36–100) and a specificity of 98% (95%CI: 96–99)
in prediction of this outcome. Absence of accelerations
together with abnormal short-term variability >63.5%,
obtained a sensitivity of 83% (95%CI: 36–100) and a
specificity of 97% (95%CI: 94–98). If abnormal long-term
variability >30.5% was combined with abnormal short-term
variability >63.5%, the sensitivity was 83% (95%CI: 36–
100) and the specificity 98% (95%CI: 96–99). The combi-
nation of all three parameters provided a sensitivity of 83%
(95%CI: 33–100) and a specificity of 96% (95%CI: 94–98).
If FHR baseline above 150 bpm was combined with the
absence of accelerations and abnormal long-term variability
>30.5%, sensitivity decreased to 16% (95%CI: 1–63), but
specificity remained at 99% (95%CI: 98–100). None of the
cases with low 5-min Apgar score exhibited prolonged,
severe or repetitive decelerations.
3.3. Prediction of umbilical artery acidemia
The ROC curves evaluating the discriminative capacity of
FHR parameters to predict arterial pH <7.20 (46 cases) and
<7.15 (15 cases) are displayed in Fig. 4. It should be noted
that, of the eight cases with 1-min Apgar 4, only three had
Fig. 2. Scatter-graphs relating the percentage of abnormal long-term variability with 1-min Apgar scores in the whole study population (on the left) and in
cases without FHR accelerations (on the right, n ¼ 26).
Fig. 3. ROC curves for the prediction of 5-min Apgar 6 (n ¼ 6) by the studied FHR parameters. On the right, areas under the ROC curves, 95% confidence
intervals, and best cut-off values for each parameter. STV: short-term variability, LTV: long-term variability.
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umbilical blood-gas parameters that were considered valid
(pH values 7.13, 7.16 and 7.19).
Absence of accelerations combined with abnormal long-
term variability >30.5% obtained a sensitivity of 11%
(95%CI: 4–24) and a specificity of 99% (95%CI: 97–100)
in prediction of arterial pH <7.20. For arterial pH <7.15
these values were 12% (95%CI: 2–39) and 98% (95%CI:
96–99), respectively. Combining absence of accelerations
with abnormal short-term variability >63.5%, provided a
sensitivity of 11% (95%CI: 4–24) and a specificity of 98%
(95%CI: 95–99) in prediction of arterial pH <7.20, and a
sensitivity of 12% (95%CI: 2–39) and a specificity of 97%
(95%CI: 94–99) in prediction of arterial pH<7.15. When
abnormal long-term variability >30.5% was combined with
abnormal short-term variability >63.5%, the sensitivity in
prediction of arterial pH <7.20 was 11% (95%CI: 4–24) and
the specificity 99% (95%CI: 97–100). For arterial pH <7.15
these values were 12% (95%CI: 2–39) and 98% (95%CI:
96–99). The combination of all three parameters provided a
sensitivity of 11% (95%CI: 4–24) and a specificity of 99%
(95%CI: 97–100) in predicting arterial pH <7.20. For arter-
ial pH <7.15 these values were 12% (95%CI: 2–39) and 98%
(95%CI: 96–99).
4. Comment
Our results show that SisPorto12.0 FHR parameters
related to the quantification of accelerations and variability
have an excellent discriminative capacity to predict 1 and 5-
min Apgar scores, and to a much lesser degree umbilical
artery acidemia. The best cut-off values determined from
analysis of accelerations, short- and long-term variability
detected both cases that went on to develop hypoxic-
ischemic encephalopathy. Addition of FHR baseline
>150 bpm to the quantification of accelerations and varia-
bility decreased the sensitivity for prediction of Apgar scores
significantly, while specificity remained high. None of the
cases with low Apgar scores exhibited prolonged, severe or
repetitive decelerations.
Fig. 4. ROC curves and areas under the curve for prediction of arterial pH <7.15 (top, n ¼ 15) and pH <7.20 (bottom, n ¼ 46). STV: short-term variability,
LTV: long-term variability).
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The programs’ classification of decelerations evolved
form the more traditional categorization as early, variable
and late. In previous versions of the program when the latter
was employed, a comparison between computer and experts
regarding the identification of decelerations, fell short due to
the surprisingly poor interobserver agreement [16] and only
marginal consensus found with visual analysis [17]. This led
us to question the clinical applicability of this classification
[17], in spite of the well documented pathophysiological
mechanisms underlying it, as demonstrated in controlled
laboratory animal studies. It is possible that the different
pathophysiological mechanisms involved in the etiology of
decelerations usually occur simultaneously during labor, and
the complexity of the originated FHR signal does not allow a
consistent categorization into one of the predefined patterns.
The simplified classification used in the current version of
the program was derived from an optimisation study invol-
ving a limited number of patients [18], the validity of which
can only truly be evaluated in a study carried out in the
intrapartum.
The closer relationship between FHR parameters and
Apgar score, as opposed to umbilical artery pH, seems
clearly justified from a physiological point of view. Being
mainly an evaluator of neurological and cardiac function, it
follows that FHR monitoring should be a better predictor of
neonatal parameters that are closely related (reflexes, muscle
tone, and heart rate) rather than circulatory acid–base bal-
ance. The susceptibility of neurological and cardiac function
to acidemia is likely to be related to its duration and
swiftness of installation, as well as to individual cellular
compensation mechanisms.
Although the best areas under the ROC curve were
obtained with analysis of long-term variability, it was cur-
ious to find that quantification of short-term variability was
also a good predictor of Apgar scores, in spite of the
autocorrelation techniques routinely employed to improve
external FHR signal quality. It has been well-demonstrated
that this methodology provides only an approximation of the
true beat-to-beat variability, and a value which is, on aver-
age, lower than that obtained by analysis of electrocardio-
graphic signals [19,20].
While in the primordials of FHR monitoring it was
established that its main objective was the prevention of
fetal death and neurological handicap, it has since been
demonstrated that these situations are frequently associated
with fetal malformations, infections, metabolic diseases, and
hypoxia occurring in the post-natal period [21]. It is not
reasonable to expect FHR monitoring to identify or prevent
such conditions, and so neonatal indicators of intrapartum
hypoxia remain the only reasonable standards with which to
compare the technique. The value of the Apgar score as an
indicator of neonatal outcome has been questioned, because
the vast majority of newborns with low estimates are known
to have a normal post-natal course, it is subject to some
interobserver variation [22] and can be affected by non-
hypoxic conditions such as prematurity, drugs, pre-existing
neurological conditions, resuscitation methods, and birth
trauma [23]. On the other had, it has a higher association
with neonatal death and long-term neurological handicap
than umbilical artery pH [24,25] and is significantly asso-
ciated with neonatal hypoxic-ischemic encephalopathy, a
condition highly predictive of long-term neurological seque-
lae [26]. It is almost certain that in the group of newborns
with low Apgar scores and/or low umbilical artery pH are
included all of those who will die or develop severe handi-
caps as a consequence of peri-partum fetal hypoxia.
It is possible that the high discriminative capacity to
predict Apgar scores was related to the inclusion of very
premature fetuses, where fewer accelerations, decreased
variability, as well as lower Apgar scores usually occur
[24,27], and that there was some interdependency between
these parameters. However, only half of the cases with 1-min
Apgar 4 had a gestational age of less than 32 weeks, and
these were the only cases in this premature group with no
accelerations and abnormal variability above the chosen cut-
off values. It thus seems likely that these FHR parameters
maintain their discriminative capacity in very premature
fetuses. Several other authors have found no significant
differences in computer quantification of variability along
the third trimester [28,29]. In particular, the lower limit of
normality seems to remain relatively constant throughout
this period [28,30,31].
The absence of fetuses with metabolic acidosis in this
antepartum population delivered by cesarean section, in
spite of documented abnormal neonatal outcomes presum-
ably due to intra-uterine hypoxia, suggests that the cut-off
values used to establish this diagnosis, derived predomi-
nantly from the study of intrapartum cases, may not be
adequate in this scenario. Further research is needed to
clarify this issue.
The Sonicaid1 System 8000/8002 has been extensively
evaluated in the antepartum, generally by analyzing the
correlation between FHR parameters and neonatal outcome
indicators, rather than their discriminative capacity
[30,32,33]. Studies comparing FHR parameters with sub-
sequent umbilical venous blood gas analysis obtained by
cordocentesis found a high correlation between long-term
variation and fetal hypoxemia [34], but the sensitivity of
abnormal tracings in prediction of moderate to severe
hypoxemia was only 45% [35].
Guzman et al. [36] studied 38 fetuses with intrauterine
growth restriction and changes in uterine and/or umbilical
Doppler waveforms, evaluating 1-h tracings acquired by
System 8000 in the 4 h preceding cesarean birth. In the
prediction of umbilical artery pH <7.20 (n ¼ 8), short-term
variation provided an area below the ROC curve of 0.97
(standard error 0.05). Using the best cut-off values deter-
mined by ROC curve analysis, short-term variation and
absence of accelerations obtained sensitivities of 100%,
and specificities of 80 and 73%, respectively, in the predic-
tion of this outcome. Confidence intervals for these results
were not reported.
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Anceschi et al. [37] retrospectively evaluated 70 uncom-
plicated term pregnancies, where antepartum tracings last-
ing more than 40 min were acquired by System 8002 in the
4 h preceding elective cesarean section. No significant cor-
relations between FHR parameters and umbilical artery
blood gas values were found. Quantification of accelerations
provided a sensitivity of 43% and a specificity of 28% in
prediction of a good neonatal outcome, defined as arterial
pH >7.20, extracellular fluid base deficit <4 mmol/l and 5-
min Apgar >7. For fetal movements sensitivity was 67% and
specificity 57%.
Using the 2CTG1 system, Arduini et al. [38] studied 37
fetuses with intrauterine growth restriction and altered
umbilical diastolic flow, evaluating tracings acquired imme-
diately before elective cesarean section. Average long-term
variability obtained a sensitivity of 77% and a specificity of
90% in prediction of umbilical artery pH <7.21. For average
short-term variability these values were 83 and 100%,
respectively.
The apparently contradictory results found in these
publications are probably due to differences in the selected
study population. In the relatively small number of cases
studied with intra-uterine growth restriction and umbilical
or uterine flow changes, a reasonable capacity of FHR
variability to predict acidemia is apparent [36,38], but this
is not the case in healthy term pregnancies [37]. It is
evident that FHR monitoring needs to be a good discri-
minator in both of these populations, but independently of
such considerations, the relatively small number of cases
evaluated in these studies casts some uncertainties on the
interpretation of results.
Our results suggest that automated quantification of
accelerations and variability is a useful adjunct to the
interpretation of antepartum FHR tracings, as it provides
a good prediction of Apgar scores and, to a much lesser
degree umbilical artery acidemia. This advantage could be
related mainly to the quantification of long- and short-term
variability, parameters in which eyeball analysis has a more
evident limitation. Considering all studies that aimed to
evaluate computerised antepartum FHR analysis and took
care to avoid biases, the number of cases evaluated in this
study is unprecedented, but in spite of this, the relatively few
poor fetal outcomes precluded a more confident evaluation
of the method’s sensitivity, a fact that is not translated by
overall ROC curve confidence intervals. The low incidence
of newborns with poor neonatal outcome is a current reality
in industrialized countries [39]. Further studies are therefore
needed to confirm the high sensitivity obtained in prediction
of Apgar scores.
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